Advertisment
About us
|
Subscription
|
e-Alerts
|
Feedback
|
Reader Login
Home
|
Current Issue
|
Archives
|
Ahead of print
|
Search
|
Instructions
|
Editorial Board
Users Online:
4642
Official publication of the Indian Society of Nephrology
~
Site Statistics
~
Addresses
~
Search
~
My Preferences
~
Online Submission
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2022| January-February | Volume 32 | Issue 1
Online since
January 28, 2022
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
ORIGINAL ARTICLES
Skin colonizers and catheter associated blood stream infections in incident Indian dialysis patients
Varun Agrawal, Anna T Valson, Yamuna Devi Bakthavatchalam, Shailesh Kakde, Anjali Mohapatra, Vinoi George David, Suceena Alexander, Shibu Jacob, John Antony Jude Prakash, Balaji Veeraraghavan, Santosh Varughese
January-February 2022, 32(1):34-41
DOI
:10.4103/ijn.IJN_400_20
Introduction:
Skin colonization is a risk factor for multi-drug resistant (MDR) catheter-associated bloodstream infections (CABSI). This study aimed to determine the prevalence and spectrum of skin colonizing MDR organisms in incident HD patients and their correlation with CABSI.
Methods:
This single-center prospective cohort study included consecutive adult incident HD patients who underwent tunneled or non-tunneled internal jugular vein HD catheter insertion between June 1, 2017 and October 31, 2017. Nasal, axillary, and exit site swabs were obtained prior to catheter insertion, at 14–21 days, and 28–35 days after catheter insertion.
Results:
Forty-three patients (69.7% male, 32.5% diabetic) were included and provided baseline swabs, while 29 and 10 patients respectively were available for follow-up swabs. MDR bacterial colonization, MRSA colonization, and MDR gram-negative colonization on the baseline set of swabs were seen in 76.7%, 69.7%, and 9.3% patients respectively. Of the 29 patients with at least two consecutive sets of swabs, 79.3% showed persistent colonization by MDR gram-positive organisms, most commonly by MRSA. Six patients developed a CABSI during the follow-up period (incidence rate 3.7 per 1000 patient days), 83.4% were gram negative, and in only one instance (16.6%) was the bacterial strain identical to that which had previously colonized the skin.
Conclusions:
Three-fourths of HD patients were colonized by MDR bacteria prior to HD initiation. Despite the majority being persistently colonized by MDR gram-positive organisms, CABSIs were predominantly gram negative.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
11,507
186
-
REVIEW ARTICLES
Banff classification from 1991 to 2019. A significant contribution to our understanding and reporting of allograft renal biopsies
Swarnalata Gowrishankar
January-February 2022, 32(1):1-7
DOI
:10.4103/ijn.IJN_270_20
The Banff schema of classification of renal allograft biopsies, first proposed at the meeting in Banff, Canada in 1991 has evolved through subsequent meetings held once in two years and is the internationally accepted scheme of classification which is consensual, current, validated and in clinical use. This review traces the evolution of the classification and our understanding of renal transplant pathology, with emphasis on alloimmune reactions. The proceedings of the meetings and the important studies which have shaped the classification are covered.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
2,769
474
-
Laparoscopic versus open-surgery catheter placement in peritoneal dialysis patients: A meta-analysis of outcomes
Guled Abdijalil, Shen Shuijuan
January-February 2022, 32(1):8-15
DOI
:10.4103/ijn.IJN_482_20
The peritoneal dialysis catheter (PDC) can be placed either through the laparoscopic technique, percutaneous technique or surgical procedures. The utilization of these PDC placement procedures is based on successful placement and reduced risk of development of complications. The main objective of this study was to compare the complications associated with laparoscopic vs. open-surgery PDC placement procedure. Literature for this review was obtained from PubMed and Google Scholar databases. The literature search was limited to studies published in the period between 1998 and 2019. The meta-analysis was done using Stata Version 12. The results showed significant difference in catheter malfunction between the laparoscopic and open-surgery group (relative risk [RR] =0.58; 95% CI: 0.42–0.8;
P
= 0.031). Furthermore, there was no significant statistical difference in dialysate leakage (RR = 0.77; 95% CI: 0.51–1.17,
P
= 0.116) peritonitis (RR = 0.8; 95% CI: 0.6–1.06,
P
= 0.349) and exit-site infection (RR = 0.84; 95% CI: 0.65–1.09,
P
= 0.834) between the laparoscopic and open-surgery PDC placement groups. In conclusion, the laparoscopic PDC placement procedure was superior to open surgery in regards to catheter malfunction. Additionally, the choice of treatment procedure should put in consideration factors such as cost and comfortability of the patient.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
2,838
238
-
ORIGINAL ARTICLES
ABO-incompatible kidney transplantation in India: A single-center experience of first hundred cases
Pranaw Kumar Jha, Shyam Bihari Bansal, Abhyudaysingh Rana, Ashish Nandwani, Ajay Kher, Sidharth Sethi, Manish Jain, Dinesh Bansal, Dinesh Kumar Yadav, Ashwini Gadde, Amit Kumar Mahapatra, Puneet Sodhi, Rajesh Ahlawat, Vijay Kher
January-February 2022, 32(1):42-46
DOI
:10.4103/ijn.IJN_465_20
Aim:
ABO-incompatible (ABOi) kidney transplantation overcomes immunological barrier of blood group incompatibility. There have been very few published experiences of ABOi kidney transplantation from India. We present our single-center experience of the first hundred ABOi kidney transplants.
Material and Methods:
This is a single-center retrospective study of consecutive first hundred ABOi kidney transplant with at least 6 months of follow-up.
Results:
During the study period (2011–2020), a total of 121 ABOi kidney transplants were performed. Of these, first hundred patients were analyzed. Median follow-up duration was 33 (10–101) months. Mean recipient and donor age were 41.5 ± 13 and 47.68 ± 11.25 years, respectively. Mean HLA mismatch was 4 ± 1.5. Median baseline anti-blood group antibody titer was 128 (2–1024). Most common recipient blood group was O. Patient and death censored graft survival was 93% and 94%, respectively, at median follow-up of 33 months. Biopsy-proven acute rejection (BPAR) rate was 17% with acute antibody-mediated rejection being 3%. Rate of infection was 37%, most common being urinary tract infection.
Conclusion:
ABOi kidney transplant patients had acceptable patient and graft survival as well as BPAR rates. With current preconditioning protocol, infection rate was high.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
2,755
278
-
Clinical profile and outcomes of coronavirus disease 2019 (COVID-19) in patients undergoing hemodialysis
Tanuj Moses Lamech, Govindasamy Nithya, Dhanapalan Aiswarya, Natarajan Gopalakrishnan, Paulpandian Vathsalyan, Shaji Sajmi, Kamalakannan Goutham, Ravindran Krishna, Thanikachalam Dineshkumar, Ramanathan Sakthirajan, Jeyachandran Dhanapriya, Rajendran Padmaraj
January-February 2022, 32(1):16-21
DOI
:10.4103/ijn.IJN_511_20
Introduction:
Several months into the coronavirus disease 2019 (COVID-19) pandemic, there remains a paucity of data on the behavior of the disease in patients with end-stage kidney disease (ESKD) on maintenance hemodialysis (MHD). Here, we describe the clinical presentations, biochemical profile, and outcomes of 183 such patients from a large tertiary-care center in South India.
Materials and Methods:
This prospective, observational study, included all patients with COVID-19 and ESKD who received at least one session of hemodialysis at our center, from the start of the outbreak to July 9, 2020. Clinical features at presentation, laboratory and radiological data, and outcomes were analyzed.
Results:
A total of 183 patients were included in the analysis. Patients who had symptoms at presentation accounted for 49.18% of the cohort, with the most common symptoms being fever (87.1%), cough (67.7%), and breathlessness (63.4%). Factors independently associated with mortality on univariate analysis included age ≥60 years, having symptoms at presentation, neutrophil–lymphocyte ratio >6, C-reactive protein >20 mg/L, serum lactate dehydrogenase >250 IU/L, CT (computed tomography) Grades 3 and 4, and the need for respiratory support. However, on multivariate logistic regression analysis, the only factor that retained significance was an age >60 years.
Conclusions:
This analysis confirms the previous reports of higher COVID-19-related mortality in the dialysis population and identifies older age, higher inflammatory markers, and greater degrees of radiological lung involvement to correlate with increased mortality.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
2,469
318
-
Revisiting vasculopathy in lupus nephritis: A renal biopsy evaluation study
Ramya Lakshmi V, Navatha Vangala, Megha S Uppin, Swarnalatha Gudithi, Gangadhar Taduri, Sree Bhushan Raju
January-February 2022, 32(1):28-33
DOI
:10.4103/ijn.IJN_131_20
Introduction:
The classification of lupus nephritis (LN) on biopsy is essentially focused on morphologic changes in glomeruli. Renal vascular lesions are not addressed in detail in current classifications and are often overlooked. We aimed to determine the prevalence of vascular lesions in LN on biopsies and to compare these with biopsies not showing the vasculopathies.
Methods:
A total of 740 renal biopsies of LN were analysedfor presence of vasculopathies from January 2013 to June 2019. Of these, 527 (71.2%) biopsies showed vascular lesions (vascular group), which were further categorized into known five subtypes according to morphology and immunofluorescence (IF) findings. Remaining 213 (28.8%) biopsies constituted non-vascular group. Clinical, demographic and laboratory parameters were compared between these two groups.
Results:
The mean age was 27.95 ± 9.8 years and 27.0 ± 9.4 years in the vascular and non-vascular groups respectively with higher M:F (1:2 > 1:7) in vascular group. Majority of vasculopathies (257, 48.7%) were found in biopsies with class IV LN. Haematuria (69.8% vs. 20.1%), proteinuria (100% vs. 62%), anemia (48.3% vs. 3.60%) and hypertension (39.8% vs. 8.46%) were common in group I. Uncomplicated vascular immune deposits (426; 80.8%) were the most common vasculopathy and true vasculitis (4;0.8%) was least common. Activity and chronicity indices (7.35 ± 3 and 2.45 ± 1.5, respectively) were significantly higher in the vascular group.Activity index was highest in uncomplicated vascular immune deposits (7.45 ± 2.8) and chronicity index was highest in non-specific sclerotic vascular lesions (2.7 ± 1.6).
Conclusion:
Vascular involvement is common in LN. Uncomplicated vascular immune deposits were common vasculopathies whereas true vasculitis was least common. The morphology and IF both need to be carefully screened for the diagnosis of vasculopathies.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
2,490
164
-
Assessment of risk factors and outcome of early versus late cytomegalovirus infection infection in living-related D+/R + renal allograft recipients
Atul Srivastava, Soumita Bagchi, Sarman Singh, Veena Balloni, Sanjay Kumar Agarwal
January-February 2022, 32(1):47-53
DOI
:10.4103/ijn.IJN_463_20
Introduction:
Cytomegalovirus infection (CMV) in a kidney transplant recipient (KTR) is a serious complication resulting in increased morbidity, mortality and reduced graft survival. There is limited data on early (within 3 months posttransplant) CMV infection (ECMVI) vs. late CMV infection (LCMVI) in patients not receiving CMV prophylaxis. In India, majority of kidney transplants are D + R + combination. This study aimed to compare the risk factors and outcome of ECMVI vs. LCMVI in living related post-KTR.
Methods:
This was a single-center ambispective study of adult KTR from living donor between January 2001 and December 2015 who had CMV infection. This study had two cohorts: retrospective and prospective. Retrospective cohort included all KTR from January 2001 to September 2014. Prospective cohort included KTR who received transplants from October 2014 to December 2015. Of both cohorts, patients with early and late CMV infection were included. All patients received triple-drug immunosuppression. CMV infection was diagnosed when KTR had detectable CMV copies > 500/mL. In the prospective cohort, CMV PCR was done at 45 days, 3, 6, 9 and 12 months in all patients. Patients with CMV were treated on conventional lines. All patients were followed up till June 2016.
Results:
Of 2175 retrospective cohort, 97 and of the 155 prospective cohorts 75 had CMV infection, total being 172 CMV infections. Of these, 90 patients had ECNVI and 82 LCMVI. Induction was used in 48.8% in ECMVI group vs. 35.3% in LCMVI group (p = 0.02). CNI toxicity was present prior to CMV infection in 15 (17.4%) in ECMVI as compared to 14 (17.9%) in LCMVI (
P
= 0.93). In the ECMVI, 6 (6.6%) had acute rejection as compared to 13 (15.8%) in the LCMVI (
P
= 0.05). While asymptomatic CMV infection was more common in early (63.3% vs 37.8%,
P
= 0.001), symptomatic CMV without tissue diagnosis was more common in late (54.8% vs. 31.1%,
P
= 0.002). Total duration of post-transplant follow-up was 22.8 ± 22.1 months in ECMVI as compared to 49.7 + 40.9 months in the LCMVI (
P
< 0.001). The serum creatinine at last follow-up was 1.9 ± 1.6 mg/dL in ECMVI group and 2.4 ± 2.0 mg/dL in LCMVI (
P
= 0.02).
Conclusion:
In D+/R + living renal transplant recipients, without routine CMV prophylaxis, late CMV infection had more tissue invasive disease and is associated with inferior graft function on long-term follow-up.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
2,462
143
-
C1q nephropathy in children with nephrotic syndrome: Treatment strategies and outcomes
Saumil Gaur, Reeba Patrick, Mahesha Vankalakunti, Kishore Phadke
January-February 2022, 32(1):54-59
DOI
:10.4103/ijn.IJN_578_20
Introduction:
There is a paucity of clinical data on C1q nephropathy (C1qN) in children in India and Southeast Asia. This is the first detailed analysis conducted to elucidate the prevalence, clinicopathological profile, and response to different immunosuppressives in children with C1qN in India.
Materials and Methods:
Detailed demographic profile, clinical features, urine and blood chemistries, kidney biopsy, and response to different immunosuppressives of the study participants were analyzed between August 2015 and October 2020 for steroid-dependent/-resistant nephrotic syndrome (NS).
Results:
C1qN was diagnosed in 16 (14.13%) of 113 children who underwent biopsy for steroid-dependent/-resistant NS. The mean age was 44 months (range 18–99 months) and male and female number was 12 (75%) and four (25%), respectively, and mean follow-up was 3.5 years. Eight (50%) had coexistent minimal-change nephrotic syndrome (MCNS) pattern, seven (43.7%) had focal segmental glomerulosclerosis (FSGS), and one (6.2%) had diffuse mesangial hypercellularity. Thirteen children had complete follow-up, of which eight (61.5%) and four (30.7%) cases presented as steroid-dependent and primary steroid-resistant NS, respectively, whereas one (7.6%) had joint pain with rashes. At presentation, seven (53.8%) had hypertension, 12 (92.3%) had nephrotic range proteinuria, and six cases (46.1%) had hematuria. Nine (75%) of 12 cases achieved complete remission with calcineurin inhibitor (CNI) therapy, and two were non responders, one was a partial responder, and one responded to mycophenolate. Of six FSGS cases, four had complete remission, one had partial remission, and one was in non-remission. Of six cases with MCNS, five had complete remission and one was in non-remission. Renal functions remained normal in all except one case who had progression to chronic kidney disease Stage 3.
Conclusion:
One out of seven children with difficult NS can have underlying C1qN. CNIs are most beneficial to attain and maintain remission. Renal functions remain normal in the majority. Along with C1q deposits, MCNS and FSGS patterns are seen equally and respond almost similarly to CNIs.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
2,367
229
-
CASE REPORTS
ABO-incompatible repeat kidney transplantation: Coping with the 'twin immunological barrier'
Narayan Prasad, Anand Chellapan, Anis Srivastava, Dharmendra Bhadauria, Anupama Kaul, Manas Patel, Amit Gupta
January-February 2022, 32(1):82-86
DOI
:10.4103/ijn.IJN_64_20
A repeat renal transplantation is believed to confer the best survival advantage for allograft failure. The scarcity of matching donors at one end, coupled with the expanding pool of ABO-incompatible (ABOi) donors at the other end, lead us to consider the option of ABOi kidney re-transplantation. However, ABOi kidney re-transplantation is associated with heightened immunological risk due to the presence of two substantial immunological barriers. Concern, queries, and uncertainty exist over the course and outcome of this option. We prospectively studied five patients who underwent live-related ABOi re-transplantation after a failed previous transplant. Four patients (mean age 40.8 ± 6.6 years, 4 males) underwent a second renal transplant, whereas one patient had a third renal transplant. All patients received desensitization with rituximab, plasmapheresis, and intravenous immunoglobulin as per routine protocol. One patient required immunoadsorption to achieve the desired Anti-ABO titer. All five patients had good graft survival. One of them developed combined antibody and cell-mediated rejection and another antibody-mediated rejection. Live-related ABOi kidney re-transplantation could be a viable option for patients with a previously failed graft.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
2,177
212
-
An unusual presentation of multiple myeloma
Ishan Parekh, Zaheer A Virani, Prashant Rajput, Hepal Vora, Shruti Tapiawala, Bharat V Shah
January-February 2022, 32(1):79-81
DOI
:10.4103/ijn.IJN_70_21
Multiple myeloma commonly presents as anemia, renal failure, bone pain, and infections. Presentation with epistaxis is extremely rare, and hence myeloma as the etiologic factor is seldom considered. We report the case of a patient who initially presented with recurrent epistaxis and then with myasthenia. It was only when he developed acute kidney injury 4 months after the initial presentation with epistaxis that a diagnosis of multiple myeloma was made.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,952
152
-
Hypervitaminosis D and acute interstitial nephritis: Tale of injections
Vaibhav Tiwari, Veronica Arora, Jitendra Rajput, Anurag Gupta, Smita Divyaveer, Sunita Bijarnia-Mahay, Pallav Gupta, Vinant Bhargava, Manish Malik, Ashwani Gupta, Anil Kumar Bhalla, DS Rana
January-February 2022, 32(1):71-75
DOI
:10.4103/ijn.IJN_389_20
A 33-year-old man came with nausea, vomiting and abdominal pain due to hypercalcaemia and renal dysfunction following two doses of intramuscular vitamin D injections. Levels of vitamin D were repeatedly above 300 ng/ml over a period of 10 months. Whole-body PET CT scan revealed a thin-walled collection in the right gluteal region. The patient refused a surgical intervention for the same. After 7 months of follow-up, the abscess ruptured spontaneously and was then surgically debrided. At this point, a history of pentazocine addiction was uncovered. One month later, vitamin D levels began to fall along with improvement in serum calcium and creatinine. This case unravels a diagnostic odyssey which ended with a simple surgical debridement. We aim to highlight that vitamin D supplementation in 'megadoses' in the presence of active infection can have an exaggerated response and may take months to resolve.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,889
181
-
Renal salt-wasting syndrome induced by neoadjuvant chemotherapy containing cisplatin – A case report
N Jinsi, A Vimala, Sreeja S Nair, R Arya, Ranjani Ravi
January-February 2022, 32(1):76-78
DOI
:10.4103/ijn.IJN_247_19
Hyponatremia is one of the most common electrolyte abnormality seen in oncology practice. The underlying pathogenetic mechanism for chemotherapy-induced hyponatremia is renal salt-wasting syndrome (RSWS) and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Fluid restriction is the treatment of choice in SIADH, whereas salt supplements is the mode of treatment in RSWS. Hence, differentiation between RSWS and SIADH is very important though difficult. Case reports of cisplatin (cis-dichloro-diammine-platinum-2)-induced RSWS and SIADH are rare in the literature. We report about a patient who developed hyponatremia, hypokalemia with excessive urinary excretion of sodium and potassium, renal glycosuria, and aminoaciduria on the third day of the first cycle of cisplatin-containing chemotherapy.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,840
139
-
An unusual clinical manifestation of plasmablastic lymphoma in a renal transplant recipient
Devika Gupta, Satish Mendonca, Tathagata Chatterjee, Arti Trehan, Lavan Singh, Rohit Tewari, Arun Joshi, Arun Dua
January-February 2022, 32(1):67-70
DOI
:10.4103/ijn.IJN_23_20
Plasmablastic lymphoma is a rapidly progressive CD20 negative large cell non-Hodgkin lymphoma with poor outcome. It occurs mostly in immunocompromised individuals and has a predilection for extranodal sites. They need to be differentiated from other entities sharing similar morphological features like poorly differentiated carcinoma, Burkitt's lymphoma, Alk positive large B cell lymphoma, Diffuse large B cell lymphoma, and anaplastic myeloma. EBV negativity in recipients, type, intensity, and duration of immunosuppressives used are certain risk factors in development of posttransplant lymphoproliferative disorders. High index of suspicion can help clinch the diagnosis early and prevent catastrophic consequences. Our renal transplant recipient presented with complaints of pain abdomen and malena for which he underwent exploratory laparotomy. Diagnosis was established on histopathology and timely treatment initiated reverted the disease.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,763
183
-
ORIGINAL ARTICLES
Is ambulatory blood pressure monitoring required for elderly hemodialysis patients during the interdialytic period? - Experience of a tertiary care center in South India
E Indhumathi, Srivatsa Angraje, Biswajith Mishra, Jayakumar Macha
January-February 2022, 32(1):60-66
DOI
:10.4103/ijn.IJN_160_20
Introduction:
Hypertension (HT) is a common and challenging problem in patients on dialysis. Routine peri-dialytic blood pressure (BP) recordings are unable to diagnose HT accurately and stratify cardiovascular risk. We report here an analysis of 2 years, single-center experience on 24-hour ambulatory blood pressure monitoring (ABPM) in elderly hemodialysis patients in the interdialytic period.
Materials and Methods:
Data of all the patients above 65 years of age undergoing hemodialysis between November 2017 and December 2019 in our hemodialysis unit and for whom 24-hour ABPM was done were collected. Demographics, clinical profile, pre- and post-dialysis BP recordings, 24-hour ABPM characteristics, and the outcome status were analyzed.
Results:
Of the 37 patients, 28 (75.7%) were males with a mean age of 67.73 years; 67.6% were diabetic. HT was found in all patients (100%), and uncontrolled HT was noted in 30 (81%) patients by ABPM. Patients with uncontrolled HT were also nondippers of BP (100%). A significant association was observed between nondippers and coronary artery disease (
n
= 27, 90%,
P
= 0.004). Masked HT was found in 9 (24.3%) patients with normal peridialytic BP (
n
= 9, 24.3%,
P
= 0.000). No significant difference was noted between diabetic and nondiabetic patients regarding dipping status or mortality. Among 37 patients, 9 (24.3%) died during follow-up with uncontrolled HT as a significant risk factor (
P
= 0.05).
Conclusion:
The prevalence of uncontrolled HT with blunted circadian rhythm was high as detected by ABPM in the interdialytic period among elderly hemodialysis patients and had a significant impact on mortality. Masked uncontrolled HT as measured by ABPM was not uncommon in patients with normal peridialytic BP.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,789
151
-
Microalbuminuria and Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL) in human immunodeficiency virus infected children
Emine A Rahiman, Pratap Kumar Patra, Deepti Suri, Amit Rawat, Surjit Singh
January-February 2022, 32(1):22-27
DOI
:10.4103/ijn.IJN_124_20
Introduction:
Renal dysfunction and progression to end stage renal disease is well known in human immunodeficiency virus (HIV) infection. We studied the role of microalbuminuria and urinary NGAL levels in children with HIV infection for the prediction of renal dysfunction.
Design and Methods:
A cross-sectional study was carried out and 60 HIV infected children, aged (18 months to 15 years) were screened for microalbuminuria by nephelometry and for uNGAL by ELISA. Thirty healthy children were screened for uNGAL for normative data in Indian children.
Results:
The prevalence of microalbuminuria in studied population was 3.3%. The mean uNGAL and uNGAL/creatinine in study population was higher than controls (26.94 ± 93.12 ng/ml vs. 88.94 ± 345.20 mcg/g, and 15.53 ± 37.52 ng/ml vs. 30.12 ± 78.66 ng/ml;
P
= 0.003,
P
= 0.002). Children with lower CD4 counts had significant higher mean Albumin Creatinine Ratio (ACR) and mean uNGAL;
P
= 0.03,
P
= 0.01.
Conclusions:
uNGAL and urine microalbumin are useful biomarkers of early tubular and glomerular injury in children with HIV infection.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,726
146
-
CASE REPORTS
Baclofen-induced neurotoxicity in chronic kidney disease: Is there a safe dose?
Prem P Varma, Geet Bajpai
January-February 2022, 32(1):87-89
DOI
:10.4103/ijn.IJN_330_20
Most cases of Baclofen toxicity have been reported in patients with impaired kidney functions, within a few days to weeks after ingestion. We report three cases of Baclofen induced encephalopathy in chronic kidney disease patients; two developed encephalopathy within 6–8 h after ingestion of a single tablet and third on 4
th
day of consuming 2.5 mg twice daily dose. All three cases recovered fully following haemodialysis treatment.
[ABSTRACT]
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,608
154
-
LETTERS TO EDITOR
COVID-19 in hemodialysis: A prospective, observational, single-center data from Eastern India
Arpita Ray Chaudhury, Smartya Pulai, Saugat Das Gupta, Abhishek Kumar, Aneesh Nanda, Jamshed Anwer, Arkaprava Chakrabarty, Manas Goswami, Abhirup Bhuinya, Sisir Naskar, Shubhabrata Pal, Koushik Bhattacharya, Atanu Pal, Dipankar Sircar, Debabrata Sen, Pradip Mukhopadhyay, Rajendra Pandey
January-February 2022, 32(1):90-91
DOI
:10.4103/ijn.IJN_457_20
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,466
132
-
An unusual cause of atypical hemolytic uremic syndrome relapse
Mehmet Mert, Mevlut Ceri, Selcuk Yuksel, Belda Dursun
January-February 2022, 32(1):94-95
DOI
:10.4103/ijn.IJN_384_20
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,468
129
-
Cytomegalovirus-related hemophagocytic lymphohistiocytosis after renal transplantation
Urmila Anandh, G Sudhakar, Seema Afroze
January-February 2022, 32(1):92-93
DOI
:10.4103/ijn.IJN_442_20
[FULL TEXT]
[PDF]
[Mobile Full text]
[EPub]
1,281
133
-
Contact us
|
Sitemap
|
Advertise
|
What's New
|
Copyright and Disclaimer
|
Privacy Notice
© Indian Journal of Nephrology
Published by Wolters Kluwer -
Medknow
Online since 20
th
Sept '07